IMMUNOGENICITY OF SINGLE COMPARED TO TWO-DOSE PRIMARY SERIES FOLLOWED BY BOOSTER DOSE OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV) IN SOUTH AFRICA: OPEN-LABEL, RANDOMISED, NON-INFERIORITY TRIAL (ID 1153)